Henry Schein (HSIC) Stock Analysis & AI Equity Report

Medical - Equipment & Services USD Explore free reports

Henry Schein (HSIC) overview

Henry Schein (HSIC) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 13,184m and operating profit of USD 653m; the year-end share price was 76.13 USD and market capitalisation was USD 8,814m. Henry Schein is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Henry Schein's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 3,245mFY 2025
Share price76.13 USDFY 2025 year end
RevenueUSD 13,184mFY 2025
Operating profitUSD 653mFY 2025
Net earningsUSD 398mFY 2025
Market capitalisationUSD 8,814mFY 2025 year end

About Henry Schein

Henry Schein distributes health care products and services primarily to dental and medical practitioners and alternate care sites. Its offerings include branded and corporate-brand merchandise, equipment, technical services, financial and consulting services, continuing education, and practice management software and e-services. The company also manufactures and sells dental implants, biomaterials, endodontic, orthodontic and orthopedic products for dental practices, laboratories, physician practices and other health care providers.

Generate the Henry Schein report

Henry Schein is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Henry Schein and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Henry Schein

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.